Myeloma Bone Disease

  • G. David Roodman

Part of the Current Clinical Oncology book series (CCO)

Table of contents

  1. Front Matter
    Pages i-x
  2. Rebecca Silbermann, G. David Roodman
    Pages 1-13
  3. Ronald C. Walker, Laurie Jones-Jackson, Twyla Bartel, Tracy Brown, Bart Barlogie
    Pages 15-62
  4. Joel S. Greenberger
    Pages 91-100
  5. Mohamad A. Hussein
    Pages 101-116
  6. Ashraf Badros
    Pages 133-149
  7. Peter I. Croucher, Karin Vanderkerken, Joshua Epstein, Babatunde Oyajobi
    Pages 151-168
  8. William C. Dougall, Michelle Chaisson-Blake, Howard Yeh, Susie Jun
    Pages 169-181
  9. Sonia Vallet, Noopur Raje
    Pages 183-198
  10. Claire M. Edwards, Gregory R. Mundy
    Pages 211-229
  11. Back Matter
    Pages 243-252

About this book


This state-of-the-art book presents the forefront in the science and clinical management of myeloma bone disease.  Assembling the work of the world's premier thought leaders, this book begins with sections on clinical presentation, imaging, and biochemical markers and then goes on to discuss radiation, surgical, and medical therapies.  Specific chapters are devoted to bisphosphonates and novel therapeutic agents, such as RANKL inhibitors, Wnt signaling inhibitors, and IMiDs.  The mechanisms of osteoclast activation and osteoblast suppression in multiple myeloma are also explored.

Myeloma Bone Disease is a valuable resource for medical, surgical, and radiation oncologists and cancer researchers.


Bisphosphonates Bone Disease Bortezomib Denosumab Kyphoplasty Multiple Myeloma Osteoblasts Osteoclasts Osteonecrosis of the jaw Radiation Therapy Vertebroplasty imaging surgery

Editors and affiliations

  • G. David Roodman
    • 1
  1. 1.Dept. MedicineUniversity of PittsburghPittsburghUSA

Bibliographic information